These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2783356)

  • 61. Host and bacterial factors associated with Haemophilus influenzae type b disease in Minnesota children vaccinated with type b polysaccharide vaccine.
    Granoff DM; Sheetz K; Pandey JP; Nahm MH; Rambeck JH; Jacobs JL; Musser J; Selander RK; Kabeer M; Murphy TV
    J Infect Dis; 1989 May; 159(5):908-16. PubMed ID: 2785147
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use.
    Black SB; Shinefield HR; Fireman B; Hiatt R
    J Infect Dis; 1992 Jun; 165 Suppl 1():S139-43. PubMed ID: 1588149
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
    J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.
    Takala AK; Eskola J; Leinonen M; Käyhty H; Nissinen A; Pekkanen E; Mäkelä PH
    J Infect Dis; 1991 Nov; 164(5):982-6. PubMed ID: 1940479
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Haemophilus influenzae type b vaccine.
    Anderson P; Pichichero ME
    Pediatrics; 1989 Jan; 83(1):145-6. PubMed ID: 2909967
    [No Abstract]   [Full Text] [Related]  

  • 67. Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older.
    Greenberg DP; Vadheim CM; Bordenave N; Ziontz L; Christenson P; Waterman SH; Ward JI
    JAMA; 1991 Feb; 265(8):987-92. PubMed ID: 1992212
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia.
    Webber SA; Sandor GG; Patterson MW; Mitchell LA; Scheifele D; Ochnio JJ; McVerry PH
    J Infect Dis; 1993 May; 167(5):1210-2. PubMed ID: 8486956
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease.
    Weinberg GA; Murphy TV; Granoff DM
    Pediatrics; 1990 Oct; 86(4):617-20. PubMed ID: 2216629
    [No Abstract]   [Full Text] [Related]  

  • 70. Antibody affinity in infants after immunization with conjugated capsular polysaccharide from Haemophilus influenzae type b.
    Hetherington SV; Rutkowski AF
    J Infect Dis; 1990 Nov; 162(5):1185-8. PubMed ID: 2230242
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine.
    Feldman S; Gigliotti F; Shenep JL; Roberson PK; Lott L
    J Infect Dis; 1990 May; 161(5):926-31. PubMed ID: 2324541
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Lieberman JM; Greenberg DP; Wong VK; Partridge S; Chang SJ; Chiu CY; Ward JI
    J Pediatr; 1995 Feb; 126(2):198-205. PubMed ID: 7844665
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
    Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
    Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
    [No Abstract]   [Full Text] [Related]  

  • 74. [Haemophilus vaccines. Their importance in tropical pediatrics].
    Bégué P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):912-6. PubMed ID: 1819437
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
    Madore DV; Johnson CL; Phipps DC; Myers MG; Eby R; Smith DH
    Pediatrics; 1990 Oct; 86(4):527-34. PubMed ID: 2216616
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Effectiveness of Haemophilus influenzae B-diphtheria conjugate vaccination in German children].
    Zielen S; Scheurer J; Rhodius U; Schäfer V; Isenberg H; Bauscher P; Schröder S; Ahrens P; Hofmann D
    Monatsschr Kinderheilkd; 1992 Dec; 140(12):852-6. PubMed ID: 1491705
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vaccination against Haemophilus influenzae type B.
    Lancet; 1986 May; 1(8489):1074-5. PubMed ID: 2871342
    [No Abstract]   [Full Text] [Related]  

  • 79. The introduction of Haemophilus influenzae B (Hib) vaccine.
    Murphy JF
    Ir Med J; 1992 Dec; 85(4):123. PubMed ID: 1473940
    [No Abstract]   [Full Text] [Related]  

  • 80. Newer Haemophilus influenzae type b vaccines and passive prophylaxis.
    Ward J
    Pediatr Infect Dis J; 1987 Aug; 6(8):799-803. PubMed ID: 3313245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.